| Literature DB >> 32727144 |
Thanh Ninh Le1, Chiu-Hsia Chiu1, Pao-Chuan Hsieh1.
Abstract
Sprouts and microgreens, the edible seedlings of vegetables and herbs, have received increasing attention in recent years and are considered as functional foods or superfoods owing to their valuable health-promoting properties. In particular, the seedlings of broccoli (Brassica oleracea L. var. Italica) have been highly prized for their substantial amount of bioactive constituents, including glucosinolates, phenolic compounds, vitamins, and essential minerals. These secondary metabolites are positively associated with potential health benefits. Numerous in vitro and in vivo studies demonstrated that broccoli seedlings possess various biological properties, including antioxidant, anticancer, anticancer, antimicrobial, anti-inflammatory, anti-obesity and antidiabetic activities. The present review summarizes the updated knowledge about bioactive compounds and bioactivities of these broccoli products and discusses the relevant mechanisms of action. This review will serve as a potential reference for food selections of consumers and applications in functional food and nutraceutical industries.Entities:
Keywords: bioactive compounds; biological activities; broccoli; microgreens; seedlings; sprouts
Year: 2020 PMID: 32727144 PMCID: PMC7465980 DOI: 10.3390/plants9080946
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1(A) Broccoli seeds. (B) Five-day-old broccoli sprouts.
Figure 2Summary of the bioactive compounds analyzed in the last ten years of broccoli sprouts and microgreens.
Analysis of glucosinolates in broccoli sprouts and microgreens.
| No. | Compounds | Molecular Formula | Germination Time | Characterization Method | Ref. |
|---|---|---|---|---|---|
|
| |||||
| 1 | Sinigrin | C10H17NO9S2 | 4–12 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS | [ |
| 2 | Gluconapin | C11H19NO9S2 | 3–12 days | HPLC-UV, HPLC-DAD-MS | [ |
| 3 | Progoitrin | C11H19NO10S2 | 3–12 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 4 | Glucocochlearin | C11H21NO9S2 | NS | HPLC-ESI-MS | [ |
| 5 | Glucoconringianin | C11H21NO9S2 | NS | HPLC-ESI-MS | [ |
| 6 | Glucoiberverin | C11H21NO9S3 | 4–12 days | HPLC-DAD | [ |
| 7 | Glucosativin | C11H21NO9S3 | NS | HPLC-ESI-MS | [ |
| 8 | Glucoiberin | C11H21NO10S3 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS | [ |
| 9 | Glucoraphenin | C12H21NO10S3 | 8 days | HPLC-DAD | [ |
| 10 | Glucojiaputin | C12H23NO9S2 | NS | HPLC-ESI-MS | [ |
| 11 | 3-Methylbutyl-GLS | C12H23NO9S2 | NS | HPLC-ESI-MS | [ |
| 12 | 3-Methylpentyl-GLS | C13H25NO9S2 | NS | HPLC-ESI-MS | [ |
| 13 | 4-Methylpentyl-GLS | C13H25NO9S2 | NS | HPLC-ESI-MS | [ |
| 14 | Glucoerucin | C12H23NO9S3 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS, UHPLC-MS/MS | [ |
| 15 | Glucoraphanin | C12H23NO10S3 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS, UHPLC-MS/MS | [ |
| 16 | C13H25NO9S3 | 4–12 days | HPLC-DAD | [ | |
| 17 | Glucoalyssin | C13H25NO10S3 | 3–12 days | HPLC-DAD, HPLC-MS/MS, HPLC-ESI-MS | [ |
| 18 | Glucohirsutin | C16H31NO10S3 | 12 days | HPLC-UV | [ |
| 19 | Diglucothiobeinin | C17H31NO14S4 | NS | HPLC-ESI-MS | [ |
|
| |||||
| 20 | Glucosinalbin | C14H19NO10S2 | 4–12 days | HPLC-DAD | [ |
| 21 | Gluconasturtiin | C15H21NO9S2 | 4–12 days | HPLC-DAD | [ |
|
| |||||
| 22 | C13H25NO9S2 | 4–12 days | HPLC-DAD | [ | |
| 23 | Glucobrassicin | C16H20N2O9S2 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS | [ |
| 24 | 4-Hydroxy-GLB | C16H20N2O10S2 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS | [ |
| 25 | 4-Methoxy-GLB | C17H22N2O10S2 | 3–12 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS | [ |
| 26 | Neoglucobrassicin | C17H22N2O10S2 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS, HPLC-MS/MS | [ |
| Total glucosinolates | 3–12 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, GOD/PAP kit | [ | ||
No., number; Ref., reference; NS, not specified; GLS, glucosinolate; GLB, glucobrassicin; HPLC-UV, high-performance liquid chromatography with an ultraviolet detector; HPLC-DAD, HPLC with a diode array detector; HPLC-DAD-MS, HPLC-DAD coupled to mass spectrometry; HPLC-MS/MS, HPLC coupled to tandem MS; UHPLC-MS/MS, ultra-HPLC coupled to MS/MS; HPLC-ESI-MS, HPLC coupled to electrospray ionization MS.
Analysis of isothiocyanates in broccoli sprouts and microgreens.
| No. | Compounds | Molecular Formula | Germination Time | Characterization Method | Ref. |
|---|---|---|---|---|---|
| 1 | Butyronitrile | C4H7N | 3–7 days | GC–MS | [ |
| 2 | Allyl isothiocyanate | C4H5NS | 4 days | GC–MS | [ |
| 3 | 2-Methyl-2-nitropropane | C4H9NO2 | 3–7 days | GC–MS | [ |
| 4 | 4-(Methylthio)-butanenitrile | C5H9NS | 5 days | GC–MS | [ |
| 5 | Butyl isothiocyanate | C5H9NS | 4–9 days | GC–MS | [ |
| 6 | Isobutyl isothiocyanate | C5H9NS | 4 days | GC–MS | [ |
| 7 | Iberin | C5H9NOS2 | 4–8 days | HPLC-DAD, UHPLC-MS/MS, GC–MS | [ |
| 8 | 4-Isothiocyanato-1-butene | C6H9NS2 | 4–9 days | GC–MS | [ |
| 9 | 3-Methylbutyl isothiocyanate | C6H11NS | 4 days | GC–MS | [ |
| 10 | Isoamyl methyl sulfoxide | C6H14OS | 3–7 days | GC–MS | [ |
| 11 | Erucin | C6H11NS2 | 3–9 days | UHPLC-MS/MS, GC–MS | [ |
| 12 | Sulforaphene | C6H9NOS2 | 8 days | UHPLC-MS/MS | [ |
| 13 | Sulforaphane | C6H11NOS2 | 2–12 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS, HPLC-MS/MS, UHPLC-MS/MS, GC–MS, GC−FID | [ |
| 14 | Indole-3-carbinol | C9H9NO | 8 days | UHPLC-MS/MS | [ |
| 15 | Indole-3-carboxylic acid | C9H7NO2 | NS | HPLC-DAD-MS | [ |
| 16 | Indole-3-acetic acid | C10H9NO2 | NS | HPLC-DAD-MS | [ |
| 17 | 1-Methoxyindole-3-carbaldehyde | C10H9NO2 | NS | HPLC-DAD-MS | [ |
| Total isothiocyanates | 8 days | UV/Vis, UHPLC-MS | [ |
UV/Vis, ultraviolet–visible spectrophotometry; GC–MS, gas chromatography combined with mass spectrometry; GC−FID, GC with a flame ionization detector.
Analysis of phenolic compounds in broccoli sprouts and microgreens.
| No. | Compounds | Molecular Formula | Germination Time | Characterization Method | Ref. |
|---|---|---|---|---|---|
|
| |||||
| 1 | Benzoic acid | C7H6O2 | 6 days | HPLC-UV | [ |
| 2 | Salicylic acid | C7H6O3 | 6 days | HPLC-UV | [ |
| 3 | C7H6O3 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ | |
| 4 | Protocatechuic acid | C7H6O4 | 5 days | HPLC-UV, HPLC-DAD-MS | [ |
| 5 | Gentisic acid | C7H6O4 | 4 days | HPLC-UV | [ |
| 6 | Gallic acid | C7H6O5 | 5–8 days | HPLC-UV, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 7 | Vanillic acid | C8H8O | 5 days | HPLC-UV | [ |
| 8 | C9H8O3 | 4–7 days | HPLC-DAD, HPLC-UV | [ | |
| 9 | Esculetin | C9H6O4 | 5 days | HPLC-UV | [ |
| 10 | Caffeic acid | C9H8O4 | 4–7 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS | [ |
| 11 | Ferulic acid | C10H10O4 | 3–14 days | HPLC-UV, HPLC-DAD, HPLC-DAD-MS | [ |
| 12 | Sinapic acid | C11H12O5 | 3–12 days | HPLC-UV, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 13 | Gallic acid hexoside | C13H16O10 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 14 | Gallic acid 4- | C13H16O10 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 15 | Sinapoyl malate | C15H16O9 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 16 | Isochlorogenic acid | C16H18O9 | 4 days | HPLC-UV | [ |
| 17 | Chlorogenic acid | C16H18O9 | 3–12 days | HPLC-DAD, HPLC-UV | [ |
| 18 | Caffeoyl-quinic acid | C16H18O9 | 3–8 days | HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 19 | 1- | C17H22O10 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 20 | 5- | C18H22O10 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 21 | Digalloyl hexoside | C20H20O14 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 22 | 1,2-Diferuloylgentiobiose | C32H38O19 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 23 | 2-Feruloyl-1-sinapoylgentiobiose | C33H40O18 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 24 | 1,2-Disinapoylgentiobiose | C34H42O19 | 7–8 days | HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 25 | 1-Sinapoyl-2,2′-diferuloylgentiobiose | C43H46O24 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 26 | 2-Feruloyl-1,2’-disinapoylgentiobiose | C44H50O22 | 7–8 days | HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 27 | 1,2-Disinapoyl-1′-ferulolylgentiobiose | C44H50O23 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 28 | 1,2,2′-Trisinapoylgentiobiose | C45H52O23 | 7–8 days | HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 29 | Gallotannic acid | C76H52O46 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
|
| |||||
| 30 | Apigenin | C15H10O5 | 5 days | HPLC-UV | [ |
| 31 | Kaempferol | C15H10O6 | 5–12 days | HPLC-UV, HPLC-DAD-MS, HPLC-ESI-MS | [ |
| 32 | Luteolin | C15H10O6 | 5 days | HPLC-UV | [ |
| 33 | Quercetin | C15H10O7 | 5–12 days | HPLC-UV, HPLC-DAD, HPLC-ESI-MS | [ |
| 34 | Myricetin | C15H10O8 | 5 days | HPLC-UV | [ |
| 35 | Astragalin | C21H20O11 | 7–8 days | HPLC-DAD, HPLC-ESI-MS | [ |
| 36 | Rutin | C27H30O16 | NS | HPLC-DAD-MS | [ |
| 37 | Robinin | C33H40O19 | 4 days | HPLC-UV | [ |
| Total phenolic compounds | 3–14 days | UV/Vis, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ | ||
| Total flavonoid compounds | 3–14 days | UV/Vis, HPLC-DAD, HPLC-DAD-MS, HPLC-ESI-MS | [ | ||
Antioxidant activity of broccoli sprouts and microgreens.
| Study Type | Germination Time | Antioxidant Activity Assays | Sample Treatment | Ref. |
|---|---|---|---|---|
| In vitro | 1–9 days | DPPH | 50% methanol | [ |
| In vitro | 3–14 days | DPPH, ABTS | 70% methanol | [ |
| In vitro | 5 days | DPPH, ABTS, FRAP | 70% methanol | [ |
| In vitro | 9 days | DPPH, FRAP | 90% methanol | [ |
| In vitro | 4–12 days | DPPH, FRAP | Methanol | [ |
| In vitro | 3–9 days | DPPH, FRAP, POD, CAT, SOD, GPX | 75% methanol | [ |
| In vitro | 7 days | TEAC, ORAC | Methanol | [ |
| In vitro | 2–9 days | T-AOC kit | 50% ethanol | [ |
| In vitro | 9 days | DPPH, T-AOC Kit | 75% methanol | [ |
| In vitro | 4 days | T-AOC Kit | 50% methanol | [ |
| In vitro | 5–7 days | DPPH, ABTS, FRAP | Methanol | [ |
| In vitro | 7 days | FRAP | 50% ethanol | [ |
| In vitro | 7 days | FRAP | Boiling water | [ |
| In vitro | 12 days | DPPH, ABTS | Ethanol | [ |
| In vitro | 3–7days | DPPH | Dichloromethane | [ |
| In vitro | 6 days | ABTS, FRAP, CHEL, LPO, LOXI, XOI, CAT | 50% ethanol | [ |
| In vitro | 3–10 days | DPPH, ABTS, FRAP | 70% ethanol, 70% methanol, boiling water | [ |
| In vitro | 3 days | DPPH | 80% methanol | [ |
| In vitro | 5–12 days | DPPH, CHEL, LPO | Boiling water | [ |
| In vitro | 3–11 days | DPPH | 80% methanol | [ |
| In vitro | 5–9 days | DPPH | 70% ethanol | [ |
| In vitro | NS | TEAC | Buffer solution | [ |
| In vitro | 7 days | DPPH, MA/GC, Carboxylic Acid | Hexane, dichloromethane, acetone | [ |
| In vitro | 8 days | DPPH, ABTS, FRAP | 60% methanol | [ |
| In vitro | 6 days | ABTS, FRAP, CHEL, LPO, LOXI, XOI, CAT, SOD | Buffer solution | [ |
| In vitro | 9 day | ORAC, TEAC | Buffer solution | [ |
| In vitro | 6 days | LOXI, XOI | 50% methanol | [ |
| In vivo | 4 days | FRAP, GPX | Male Wistar rats’ plasma | [ |
| In vivo | NS | NQO1, HO-1 | Female SKH-1 mice’ skin tissue | [ |
ABTS, 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid decolonization activity; DPPH, 2,2-diphenyl-1-picrylhydrazy radical scavenging activity; FRAP, ferric reducing-antioxidant power; TEAC, trolox equivalent antioxidant capacity; ORAC, oxygen radical absorbance capacity; POD, peroxidase activity; CAT, catalase activity; SOD, superoxide dismutase activity; GPX, glutathione peroxidase activity; CHEL, metal chelating activity; LPO, inhibition of lipid peroxidation; LOXI, inhibition of lipoxygenase; XOI, inhibition of xanthine oxidase; NQO1, NAD(P)H-quinone acceptor oxidoreductase 1; HO-1, heme oxygenase-1; MA/GC, malonaldehyde/gas chromatography.
Anticancer activity of broccoli sprouts and microgreens.
| Study Type | Germination Time | Subjects | Potential Mechanisms | Ref. |
|---|---|---|---|---|
| In vitro | 3–7 days | HepG2, CT26 cells | Inhibiting cell proliferation | [ |
| In vitro | 5 days | PC-3 cells | Inducing apoptosis; increasing ROS generation | [ |
| In vitro | 4 days | HepG2, SW480, BJ cells | Inhibiting cell proliferation; inducing apoptosis | [ |
| In vitro | 4–12 days | MAT-LyLu, AT-2 cells | Inhibiting cell proliferation and motility | [ |
| In vitro | 5 days | HepG2, Caco-2, A549, FL83B cells | Inducing cell cycle arrest and apoptosis; decreasing MMP level | [ |
| In vitro | 5 days | Caco-2, HT-29, HepG2 cells | Inhibiting cell proliferation | [ |
| In vitro | 8 days | U251, MCF-7, 786-0, NCI-H460, HT-29 cells | Inhibiting cell proliferation | [ |
| In vitro | 5 days | AGS cells | Inhibiting cell proliferation and motility | [ |
| In vitro | 7 days | LNCaP, PC-3, DU-145 cells | Decreasing PSA secretion; inducing apoptosis | [ |
| In vitro | NS | MCF7, SUM159 cells | Inhibiting cell proliferation; inducing apoptosis | [ |
| In vitro | NS | A549, H460, H446, HCC827, H1975, H1299 cells | Inhibiting cell proliferation; inducing apoptosis | [ |
| In vitro | NS | Caco-2, CCD18-Co cells | Inducing cell cycle arrest and apoptosis; decreasing MMP level; increasing ROS generation | [ |
| In vivo | NS | Female NOD/SCID mice | Eliminating breast CSCs in vivo; downregulating Wnt/β-catenin pathway | [ |
| In vivo | NS | Female nude BALB/c mice | Inhibiting the PI3K-AKT signaling pathway | [ |
| In vivo | 3 days | Female SKH-1 hairless mice | Stabilizing p53; inducing phase 2 enzyme; inhibiting iNOS upregulation | [ |
| In vivo | NS | Male TRAMP mice in C57BL/6 background | Decreasing HDAC3 protein expression | [ |
| In vivo | NS | SV40 and Her2/neu mice | Modulating epigenetic pathways; regulating epigenetic-controlled gene expression | [ |
| In vivo | NS | Female Her2/neu mice | Regulating tumor- and epigenetic-related gene expression; increasing tumor suppressor gene expression | [ |
| In vivo | 3 days | Female Sprague-Dawley rats | Inducing GST and NQO1 | [ |
HepG2, hepatocellular carcinoma cell line; PC-3, AT-2, MCF-7, LNCaP, DU-145, and SUM159, prostate carcinoma cell lines; A549, NCI-H460, H460, H446, HCC827, H1975 and H1299 lung carcinoma cell lines; CT26, SW480, Caco-2, and HT-29, colorectal adenocarcinoma cell lines; U251, glioma carcinoma cell line; 786-0, kidney carcinoma cell line; AGS, gastric adenocarcinoma cell line; MAT-LyLu, malignant carcinoma cell line; BJ, normal skin fibroblast cell line; FL83B, normal liver cell line; CCD18-Co, normal colon fibroblast cell line; NOD/SCID, nonobese diabetic/severe combined immunodeficient mice; TRAMP, transgenic adenocarcinoma of the mouse prostate mice; SV40, transgenic C3(1)-SV40 Tag (FVB-Tg(C3-1-TAg)cJeg/JegJ) mice; Her2/neu, transgenic FVB/N-Tg(MMTVneu)202Mul mice; MMP, mitochondrial membrane potential; PSA, prostate-specific antigen; CSCs, cancer stem cells; HDAC, histone deacetylase enzymes; GST, S-transferase; NQO1, NAD(P)H-quinone acceptor oxidoreductase 1.
Figure 3Summary of the biological activities of broccoli sprouts and microgreens with possible mechanisms of action.